Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Concentrix Corporation (NASDAQ: CNXC) SEC filings page on Stock Titan provides access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. As a Fortune 500 public company, Concentrix uses SEC reports to communicate details about its financial performance, risk factors, capital structure, and significant corporate events.
Among the key filings, investors typically review annual reports on Form 10-K and quarterly reports on Form 10-Q to understand revenue trends, operating income, non-GAAP measures referenced in earnings releases, cash flow, and segment information. Current reports on Form 8-K, such as those furnished for quarterly earnings announcements, give timely updates on results of operations and financial condition, and may include press releases as exhibits.
For those tracking ownership and governance, Forms 3, 4, and 5 (if available) can be used to monitor insider transactions by directors, officers, and significant shareholders. Proxy statements on Schedule 14A, when filed, typically provide information on executive compensation, board structure, and matters submitted to shareholder votes.
On Stock Titan, Concentrix filings are supplemented with AI-powered summaries that explain the main points of lengthy documents in clear language. Real-time updates from the EDGAR system help users see new CNXC filings as they appear, while AI-generated highlights make it easier to identify sections related to non-GAAP metrics, AI and technology investments, and other topics emphasized in the company’s earnings materials. This page is a useful starting point for anyone researching Concentrix’s regulatory history, financial reporting practices, and material disclosures.
Concentrix Corporation issued and sold $600,000,000 aggregate principal amount of 6.500% Senior Notes due 2029 in a registered public offering. The company used the net proceeds, together with other funds, to redeem $600 million of its 6.650% Senior Notes due August 2, 2026.
The new notes pay 6.500% interest semi-annually starting September 1, 2026 and mature on March 1, 2029. Their interest rate may be adjusted if Moody’s, S&P or Fitch change the notes’ debt rating. The notes are callable, with a make-whole call before February 1, 2029 and par redemption thereafter.
Concentrix Corporation is issuing $600 million of 6.500% Senior Notes due 2029 in a public offering under an effective shelf registration. The company has entered into an underwriting agreement led by BofA Securities and J.P. Morgan, with closing expected on February 24, 2026, subject to customary conditions.
Concentrix expects to use the net proceeds, together with other funds, to redeem or otherwise repay all or a portion of its 6.650% Senior Notes due August 2, 2026 and pay related fees and expenses. It has notified holders that $600 million of the currently outstanding $800 million aggregate principal amount of these 2026 Notes will be redeemed on February 24, 2026.
Concentrix Corporation is asking stockholders to vote at its virtual 2026 annual meeting on March 25, 2026. Holders of 61,287,407 eligible common shares as of January 27, 2026 can attend and vote online.
Stockholders will elect nine directors, ratify Ernst & Young as auditor, cast an advisory say‑on‑pay vote, and decide on an amendment to the 2020 Stock Incentive Plan to increase available shares. The proxy also highlights 2025 results, including about $9.8 billion in revenue, a GAAP net loss of $1.28 billion, non‑GAAP net income of $743.4 million, and returning roughly $258 million to stockholders while reducing net indebtedness by $184 million.
Concentrix Corporation is issuing $600 million of 6.500% senior unsecured notes maturing March 1, 2029. The notes pay semi-annual interest starting September 1, 2026 and the coupon can step up by up to 2.000 percentage points if credit ratings are downgraded.
Concentrix expects net proceeds of about $595.2 million, to be used with other funds to redeem or repay part or all of its outstanding $800 million 6.650% senior notes due August 2, 2026. The new notes are redeemable at Concentrix’s option, include a change-of-control repurchase feature at 101% of principal, are not guaranteed by subsidiaries, and will not be listed on any securities exchange.
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended Schedule 13G reporting beneficial ownership of 2,950,287 shares of Concentrix Corp common stock, representing 4.74% of the class as of 12/31/2025. Both entities report no sole voting or dispositive power over the shares, but shared voting and shared dispositive power for the full amount. The firms state the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Concentrix.
Concentrix Corporation plans a new unsecured senior notes offering to raise cash in the bond market. The notes will pay fixed interest semi-annually and mature on a specified future date, with the coupon step‑up feature tied to ratings from Moody’s, S&P and Fitch, capped at an extra 2.000 percentage points.
Concentrix expects to use the net proceeds, together with other funds, to redeem or repay all or part of its 6.650% senior notes due August 2, 2026, of which $800 million is outstanding, and to pay related fees. The new notes rank equally with the company’s other unsecured senior debt and are structurally subordinated to subsidiary obligations, including about $537 million of subsidiary debt within a broader $4.6 billion total debt load as of November 30, 2025. The company does not plan to list the notes, so liquidity will depend on dealer market‑making.
Concentrix Corp executive Cormac J. Twomey reported a routine share transaction. On 02/01/2026, he disposed of 1,439 shares of Concentrix common stock in a transaction coded "F" at a price of $37.35 per share. Following this activity, he directly beneficially owned 56,995 common shares as EVP, Global Ops & Delivery.
Concentrix Corp President and CEO Christopher A. Caldwell, who also serves as a director, reported a disposition of company common stock. On 02/01/2026, he disposed of 5,693 shares at a price of $37.35 per share, in a transaction coded "F."
Following this transaction, Caldwell directly beneficially owned 356,382 shares of Concentrix common stock. The filing is made as a single‑person Form 4, reflecting his status as both an officer and director of the company.
Concentrix Corp's Chief Financial Officer reports a small share disposition. CFO Andre S. Valentine filed a Form 4 showing the disposition of 864 shares of Concentrix common stock on February 1, 2026, at a price of $37.35 per share under transaction code "F," typically used for tax withholding on equity awards.
After this transaction, Valentine directly beneficially owns 86,566 shares of Concentrix common stock. The filing reflects routine insider equity administration rather than a large open-market trade.